摘要
目的分析卵巢子宫内膜异位症患者腹腔镜术后联合地诺孕素的治疗效果及对疾病复发率的影响。方法选取2020年7月至2021年12月揭阳市人民医院收治的30例卵巢子宫内膜异位症患者为研究对象,根据随机数字表法分为对照组、观察组,每组各15例。对照组行腹腔镜术后予以戈舍瑞林治疗,观察组行腹腔镜术后予以地诺孕素治疗。比较两组患者的临床治疗效果、症状评分、卵巢储备功能水平,并观察复发情况。结果两组临床总有效率比较,差异无统计学意义(P>0.05)。观察组术后6个月症状评分低于对照组,差异有统计学意义(P<0.05)。观察组术后6个月血清抗米勒管激素及窦卵泡计数均高于对照组,差异有统计学意义(P<0.05)。两组术后均未见复发。结论卵巢子宫内膜异位症患者腹腔镜术后联合地诺孕素治疗,可积极促进患者术后卵巢功能恢复,改善临床症状,效果显著,且可控制患者术后复发风险。
Objective To analyze the therapeutic effect of combined Dienogest after laparoscopic surgery in patients with ovarian endometriosis and its influence on the recurrence rate.Methods A total of 30 patients with ovarian endometriosis in Jieyang People’s Hospital from July 2020 to December 2021 were selected as research subjects,and they were divided into control group and observation group according to random number table method,with 15 cases in each group.The control group was treated with Goserelin after laparoscopy and the observation group was treated with Dienogest after laparoscopy.The clinical therapeutic effect,symptom scores,and ovarian reserve function levels of the two groups were compared,and recurrence was observed.Results There was no significant difference between the two groups in clinical total effective rate(P>0.05).The symptom scores of the observation group were lower than those of the control group at 6 months after surgery,and the differences were statistically significant(P<0.05).The serum anti-Müllerian hormone and antral follicle count in the observation group were higher than those in the control group at 6 months after surgery,and the differences were statistically significant(P<0.05).There were no recurrences in either group after surgery.Conclusion The combination of Dienogest after laparoscopic surgery in patients with ovarian endometriosis can actively promote the recovery of postoperative ovarian function and improve clinical symptoms with significant effects,and can control the risk of postoperative recurrence.
作者
郭冬瑾
GUO Dongjin(Department of Gynecology,Jieyang People’s Hospital,Guangdong Province,Jieyang 522000,China)
出处
《妇儿健康导刊》
2023年第6期45-47,50,共4页
JOURNAL OF WOMEN AND CHILDREN'S HEALTH GUIDE
基金
广东省揭阳市医疗卫生科技创新项目(YLWS086)。
